Pupillary Effects of Levodopa Therapy
- 16 July 1970
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 283 (3) , 120-123
- https://doi.org/10.1056/nejm197007162830303
Abstract
In a patient with Parkinson's disease and subclinical postganglionic Horner's syndrome anisocoria developed during chronic oral L-dopa therapy. This provided an opportunity to investigate the mechanism of action of L-dopa and dopamine on the sympathetic innervation of the eye. Five patients, one of whom had a postganglionic Horner's syndrome without Parkinson's disease, served as controls.Keywords
This publication has 11 references indexed in Scilit:
- MYDRIATIC RESPONSES TO SYMPATHOMIMETIC AMINES IN PATIENTS TREATED WITH L-DOPAThe Lancet, 1969
- Action of dopamine on the human irisBMJ, 1969
- Treatment of Parkinsonism With LevodopaArchives of Neurology, 1969
- Possible Role of Dopamine as Transmitter To Promote Discharge of LH-Releasing FactorEndocrinology, 1969
- ParkinsonismNeurology, 1967
- IN VITRO RELEASE AND UPTAKE OF NORADRENALINE IN THE RAT IRISPublished by Elsevier ,1966
- Different types of sympathomimetic α-receptorsJournal of Pharmacy and Pharmacology, 1965
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960
- On the Presence of 3-Hydroxytyramine in BrainScience, 1958
- A LAW OF DENERVATIONThe Lancet Healthy Longevity, 1939